Results 11 to 20 of about 178,280 (162)
Ocular myasthenia gravis management
Ocular myasthenia gravis (OMG) has no agreed-upon diagnostic and management criteria, leading to misdiagnoses and often misguided treatments. The purpose of this minireview is to provide guidance to clinicians who encounter possible OMG patients. We cite
Mark J. Kupersmith +2 more
doaj +4 more sources
Ocular myasthenia gravis in a setting of thyrotoxicosis
Ocular myasthenia gravis in conjunction with thyroid disorders, although rare, has been reported in the past. However, the similarity in the presentation of both the entities and the tendency of myasthenia gravis to get overlooked easily, even by ...
Sarabjeet Chhabra, B C Pruthvi
doaj +4 more sources
Ocular myasthenia gravis: A review
Myasthenia gravis (MG) is a disease that affects the neuro-muscular junction resulting in classical symptoms of variable muscle weakness and fatigability. It is called the great masquerader owing to its varied clinical presentations.
Akshay Gopinathan Nair +3 more
doaj +4 more sources
Ocular myasthenia gravis: Side effect of urografin
Ocular myasthenia gravis is an autoimmune disorder of the neuromuscular junction. Diplopia and ptosis are common symptoms at the onset of ocular myasthenia gravis. It may occur due to the antibodies developed against various drugs.
Nitin Modi +3 more
doaj +2 more sources
Early onset bilateral juvenile myasthenia gravis masquerading as simple congenital ptosis
Myasthenia gravis is an autoimmune disorder affecting the neuromuscular junction. Ocular myasthenia gravis presents as ptosis with extraocular motility restriction and is prone to be misdiagnosed as third nerve palsy or congenital or aponeurotic ptosis ...
Alam, Md. Shahid, Devi Nivean, Pratheeba
doaj +2 more sources
Treatment of Ocular Myasthenia Gravis
Myasthenia gravis is a relatively common neuromuscular disorder, with ocular myasthenia gravis being a subset defined as myasthenia gravis limited to the orbicularis, levator, and extraocular muscles. Patients with ocular myasthenia gravis can have disabling diplopia or functional blindness from ptosis and in most cases treatment is required.
Michael Lee
openaire +3 more sources
Frontalis sling procedure for ocular myasthenia gravis
Shinichi Asamura1, Hirohiko Kakizaki2, Mitsuhiro Enjyo1, Takahiro Hashimoto1, Noritaka Isogai11Department of Plastic and Reconstructive Surgery, Kinki University School of Medicine, Osakasayama, Osaka, Japan; 2Department of Ophthalmology, Aichi Medical ...
Isogai N +4 more
doaj +1 more source
Thymectomy in the treatment of ocular myasthenia gravis [PDF]
Thymectomy is an effective and accepted treatment for myasthenia gravis, but thymectomy for ocular myasthenia gravis (Osserman stage I) is controversial.To assess the efficacy and propriety of thymectomy for the treatment of ocular myasthenia gravis.We conducted a review and follow-up of all patients who had thymectomy for the treatment of ocular ...
Peter F. Roberts +7 more
openaire +3 more sources
Trauma-Induced Double-Seronegative Ocular Myasthenia Gravis: A Case Report [PDF]
We present here a 12-year-old child who presented with complaints of blurring of vision and drooping of the left upper eyelid for the past 4 years, which started 1 month after he encountered blunt trauma to the left-sided orbital region.
Mohammad Ali Khalid +5 more
doaj +2 more sources
Seronegative Maternal Ocular Myasthenia Gravis and Delayed Transient Neonatal Myasthenia Gravis
BackgroundâMyasthenia gravis (MG) is an autoimmune disorder with fluctuating muscle weakness, divided into generalized and localized (ocular) forms.
Naveed Hussain, Courtney Townsel
exaly +3 more sources

